HLA-C and neoplasm: (76) developed a transfer learning-based pMHC-TCR binding prediction network, pMTnet, to predict the TCR binding specificities of neoantigens presented by MHC I. The training and prediction of pMTnet is based on the sequence of mutually recognized antigens during T-cell-tumor cell binding, the MHC sequence and the TCR sequence.